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A b s t r a c t : Background and objectives: In this study we assesed the effect of 
a small dose of ketamine on the production of TNFα, IL-1β and IL-6 and the postopera-
tive pain in patients undergoing laparoscopic cholecystectomy. 
Methods: Fifty patients undergoing laparoscopic cholecystectomy were rando-
mized in two equal groups. Patients in the ketamine group after induction in anesthesia 
received ketamine – 025 mg/kg-1. At the same time patients from the control group 
received sodium chloride. Postoperatively, the pain was assessed with VAS at periods 
of 30 min at 1, 2, 4, 8, 18, 24 and 48 hours. TNFα, IL-1β and IL-6 were evaluated 
before surgery at 4, 18 and 24h after the operation. 
Results: Differences of mean values of TNFα and IL-1β between the two 
groups in the postoperative period were not significant. Mean values of IL-6 in the inve-
stigated group A were significantly lower than the mean values of IL-6 in the investiga-
ted group B after the 4th hour (p = 0.00990), after the 18th hour (p = 0.00133) and as 
after the 24th hour following surgery (p = 000860). the difference in pain intensity 
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according to the VAS scale was also statistically significantly smaller in group A after 
30 min, 1,2,8 and 12 hours after surgery. 
Conclusions: The addition of a small-dose of ketamine in patiens undergoing 
laparoscopic cholecystectomy resulted in attenuation of secretion of TNFα, IL-1β, IL-6 
and reduction of postoperative pain.  
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Introduction 
 
 Laparoscopic surgery has an established place in modern general surgi-
cal practice, and provides many benefits over open surgery in patients, inclu-
ding reduction of hospitalization and recovery time, less postoperative pain, a 
better cosmetic outcome, a lower risk of incisional hernias, and an earlier return 
to normal activities [1]. However, the pneumoperitoneum itself is not a safe 
procedure, as evidenced by several structural and functional alterations obser-
ved after its use [2–4]. Surgery and anaesthesia elicit a characteristic response 
involving the metabolism, induction of synthesis and release of acute-phase 
proteins such as C- reactive protein (CRP), an increase in circulating concentra-
tions of stress hormones (cortisol and catecholamines) and synthesis and release 
of various mediators, e.g. cytokines [5]. The inflammatory cytokines, such as 
tumour necrosis factor (TNFα), interleukin-1 (IL-1β) and interleukin-6 (IL-6) 
are all considered to be important mediators of the pathophysiological changes 
associated with surgery. 
 In animals, interleukin-1 (IL-1β) has been reported to be a potent activa-
tor of the hypothalamic-pituitary axis and it has been suggested that IL-1β also 
acts directly on the hypothalamus to induce the release of norepinephrine [6]. 
Plasma IL-6 levels rise after surgery and this rise reaches its peak between 6 and 
12 hours after operation. It has been shown to be proportional to the severity of 
surgical injury and it is considered to be a sensitive indicator of surgical trauma 
[7–8]. Plasma IL-6 level is greater after hip replacement than after cholecys-
tectomy [7]. After abdominal surgery, increased IL-6 levels were demonstrated 
without a simultaneous increase in IL1β and TNFα [9], while cardiopulmonary 
bypass has been associated with increased blood levels of IL-6 [10], as well as 
IL1β and TNFα [11]. Interleukin-6 is a very important inflammatory cytokine in 
the physiology of nociception and the pathophysiology of pain [12]. 
 Effective pain management may affect the immune responses during 
the postoperative period. An attempt to diminish deleterious side-effects of the 
opiates on the immune system could be achieved by the addition of drugs with 
marked analgesic activity capable of attenuating pain stimuli and therefore 
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allowing reduction of the dosage of opiates. Ketamine, a neurotransmitter acting 
as an N-methyl D-aspirate receptor antagonist, has been shown to enhance the 
effect of morphine in control of perioperative pain. Cherry and colleagues have 
achieved reduction in morphine dosage and pain score by the addition of keta-
mine, with a direct relationship between ketamine dosage and pain score [13]. 
Similar results have been observed in patients undergoing knee or abdominal 
surgery [14]. In patients who received a small dose of ketamine and underwent 
coronary artery bypass and abdominal hysterectomy, Roytblat and colleagues 
have reported a decrease in serum IL-6 [15, 16].  
 The present study was designed to assess the postoperative pain and 
immunomodulatory effect of a sub-anesthetic dose of ketamine on the serum 
production of tumour necrosis factor (TNFα), interleukin-1 (IL-1β) and interleu-
kin-6 (IL-6) in patients undergoing laparoscopic cholecystectomy.  
 
 
Methods 
 
 Fifty patients, ASA grade I or II, undergoing elective laparoscopic 
cholecystectomy were recruited at the University Anaesthesiology, Reanimation 
and Intensive Care Medicine Clinic within the period from August 2010 to 
November 2010. Severe hepatic, renal, cardiovascular or psychological disor-
ders, malignant disease, immune system disorders, alcoholism or an inability to 
understand the study protocol were exclusion criteria. The day before surgery 
the patients were introduced to the concept of the visual analog scale (VAS) 
consisting of a 100-mm line ranging from "no pain" to "strongest possible pain".  
 The patients were premedicated with diazepam 5–10 mg given orally 90 
min before operation and with i.v. administration of midazolam 2–3 mg upon 
arrival at the operating theatre. Anaesthesia was induced by i.v. administration 
of fentanyl 2–3 µg/kg-1, propofol 1–2 mg/kg-1, atracurium 0.5 mg/kg-1, and 
maintained with nitrous oxide mixtures with oxygen and sevofluorane. All 
patients were mechanically ventilated with 12–14 breaths per minute and the 
tidal volume of 8–10 ml per kilogram of body weight. The end-tidal carbon 
dioxide concentration was maintained between 35 ± 45 mmHg. 
 The patients were randomized into two equal groups. Group A (keta-
mine group) comprised 25 patients who after 5 minutes of the induction of ana-
esthesia received racemic 025 mg/kg-1 ketamine. The dose of ketamine was cho-
sen according to previous experience [16]. Group B (control group) consisted of 
25 patients who received a similar volume of isotonic sodium chloride 5 minu-
tes after induction of anesthesia. In the recovery room all patients were monito-
red for one hour, after which time the patients were returneda to the ward. 
Analgesia in the postoperatrive period was provided with i.v. admini-
stration of 100 mg ketoprofen. If the patient was still not comfortable or had a 
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pain score of more than 30 mm according to the visual analog scale (VAS), we 
administered IV 100 mg tramadol. Postoperatively, the patients were intervie-
wed about the severity of pain according to a visual scale (VAS) at periods of 
30 min., 1, 2, 4, 8, 18, 24 and 48 hours. 
 
 Immunological assays  
 Venous blood samples (10 ml) from the peripheral vein were collected 
before surgery and 4, 18 and 24 h after operation. Blood samples were centrifu-
ged at 4000 rpm for 5 min at 4°C. Serum was separated within 30 minutes to 2 
hours from taking the blood sample, to prevent loss of activity, enzymatic 
degradation and inactivation of cytokines (some of the factors that cause clot-
ting may cause activation of cytokines/receptors). Until the time of performing 
the analysis, serum samples were stored at -70°C. The concentration of proin-
flammatory cytokines was quantified using enzyme-linked immunosorbent 
assays (ELISA) (GE Healthcare, AmershamTM).  
 The assay system was based on utilization of two different types of 
antibodies. The first antibodies were attached to the solid phase of the test (96 
well microplates) and had a great affinity for interleukin found in the sample. 
The second antibody was specific for different epitopes of the interleukin. This 
antibody, the so-called detection antibody, was linked to the enzyme biotin. 
"Amplifier solution" was added to this complex, which represented a conjugate 
chain of dextran. This amplification reagent bound a large number of molecules 
of HRP (horseradish peroksidase). The binding of antibodies became evident 
when the enzyme bound to the second antibody reacted with the added substrate 
3.3; 5.5 tetra-methyl benzedin (TMB). After a while the reaction was stopped 
by adding sulfuric acid. Finally, a reading of the colouring was made using the 
ELISA reader on 450 nm. The normal range for TNFα, IL-1β and IL-6 are 0, 
9–4,9 pg/mL, 0–1,5 pg/mL and = 0–14,9 pg/mL. 
  
Statistical analysis 
 Statistical analysis was performed with the Statistical Package of the So-
cial Sciences (SPSS) for Windows. All values were shown as a mean ± (SD). For 
parametric data (serum concentration of the TNFα, IL-1β and IL-6) groups were 
compared with analysis of variance (ANOVA) and the Student t-test for dependent 
and independent samples. For attributive date we used Friedman ANOVA and the 
Mann-Whitney U Test. A value of P < 0.05 was regarded as significant. 
 
 
Results 
 
A total of 25 examinees who underwent laparascopic cholecystrectomy 
by adding ketamine (group А, n = 25), and 25 examinees undergoing laparasco-
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pic cholecistectomy without added ketamine (group B, n = 25) were analased in 
this study. The mean age of the examinees in group A was 58 ± 10 years, while 
in group B it was 55 ± 12 years, and the analysis showed that there was no 
statistically significant difference (Student t-test: p = 0.3417) (Table 1). As for 
the gender, an almost identical number of men and women were included in 
both groups (Mann-Whitney: p = 0.8083) (Table 1). The average body weight 
of the investigated group A was 78 ± 17 kg, and in group B it was 79 ± 13 kg. 
The analysis showed that concerning this parameter, there was no significant 
difference (Student t-test: p = 0.8163) (Table 1).  
 ASA I classification was recorded in 15 (60%) patients in group A and 
in 14 (56%) patients in group B, while in the other 10 (40%) patients from 
group A and 11 (44%) patients from group B, ASA classification II was recor-
ded, and the differences were not statistically significant (Mann-Whitney: p = 
0.7787) (Table 1). 
 
Table 1 
 
Mean values and per centages of examinees in investigated groups A and B according  
to investigated variables and significance of differences 
 
Variables A group –  
(Ketamine group) 
B group –  
(Control group) 
Significant 
differences (p) 
Age (yr.) Mean ± std.dev. 
58 ± 10 
Mean ± std.dev. 
55 ± 12 
0.3417 
Sex (M/F) 12 (48%) / 13 (52%) 13 (52%) / 12 (48%) 0.8083 
Weight (kg) Mean ± std.dev. 
78 ± 17 
Mean ± std.dev. 
79 ± 13 
0.8163 
ASA I / II 15 (60%) / 10 (40%) 14 (56%) / 11 (44%) 0.7787 
*significant difference 
  
As to the mean values of IL-1β, IL-6 and TNFα in the four periods, we 
made an analysis between both investigated groups. Thus it was found that 
concerning the IL-1β and TNFα there were also no statistical differences bet-
ween the two groups in the four time periods.  
 As to IL-6, the mean values in the investigated group A were statisti-
cally significantly lower than the mean values of IL-6 in the examinees from 
group B, after 4 hours (Studentt-test; p = 0.0099), after 18 hours (Student t-test; 
p = 0.0013) as well as 24 hours after the end of the operation (Studentt-test; p = 
0.0086) (Table 2).  
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Table 2 
 
Mean values of IL-1β, IL-6 and TNFα in examinees of investigated groups A and B  
and significance of differences  
A group – 
(Ketamine group) 
B group – (Control 
group) 
 
Variables 
Mean Std. Dev. Mean Std. Dev. 
Significant 
differences 
(p) 
bеforе op, 1.141 0.326 1.293 0.379 0.1345 
after 4 h 1.207 0.301 1.265 0.262 0.4793 
after 18 h 1.178 0.274 1.210 0.231 0.6535 
 
IL–1β 
after 24 h 1.972 3.398 1.167 0.214 0.2429 
bеforе op, 1.742 0.908 2.332 2.904 0.3370 
after 4 h 4.637 4.026 14.508 17.929 0.0099* 
after 18 h 10.797 9.185 25.889 20.147 0.0013* 
 
IL–6 
after 24 h 9.352 7.897 20.258 18.272 0.0086* 
bеforе op, 0.169 0.028 0.228 0.292 0.3194 
after 4 h 0.165 0.025 0.607 2.223 0.3245 
after 18 h 0.175 0.026 0.285 0.319 0.0933 
 
TNFα 
after 24 h 0.226 0.171 0.179 0.032 0.17801 
*significant difference 
  
 The pain level according to VAS scale was followed up in both groups 
30 minutes, 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 18 hours and 24 hours 
after the operation.  
 The analysis according to Friedman ANOVA (in the group) showed 
that there were statistically significant differences in pain intensity according to 
the VAS scale in the early postoperative period in the examinees from group A 
(ANOVA Chi Sqr: = 145.0 df = 8 p = 0.000001) and in the examinees from 
group B (ANOVA Chi Sqr: 174.8 df = 8 p = 0.000001). 
 The analysis according to the Mann-Whitney U Test showed that the 
differences in pain intensity according to the VAS scale were statistically 
significantly lower in group A 30 min. (p = 0.000001), 1 hour (p = 0.0019), 2 
hours (p = 0.000001), 8 hours (p = 0.0104) and 12 hours after the operation (p = 
0.0004) but there were no differences in pain intensity according to the VAS 
scale after 4 hours ( p = 0.0667), 18 hours (p = 0.9845), 24 hours (p = 0.6276) 
and after 48 hours (p = 1.0). (Table 3 and Figure 3.) 
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Table 3 
 
Mean values of VAS according to hours in examinees from A and B groups 
and significance of differences 
A group – (Ketamine 
group) 
B group – (Control 
group) 
 
VAS 
Mean Std. Dev. Mean Std. Dev. 
Significant 
differences 
(p) 
30 min 3.60 0.86 5.80 0.65 0.000001* 
1 h 3.60 0.50 4.24 0.59 0.0019* 
2 h 2.60 0.50 3.84 0.47 0.000001* 
4 h 3.00 0.57 3.36 0.57 0.0667 
8 h 2.52 0.58 3.04 0.61 0.0104* 
12 h 2.28 0.46 2.92 0.49 0.0004* 
18 h 2.04 0.45 2.04 0.61 0.9845 
24 h 1.48 0.51 1.56 0.50 0.6276 
48 h 1.20 0.41 1.20 0.41 1.0 
*significant difference 
 
 
Figure 1 –  Mean values of VAS according to hours in investigated groups A and B 
VA
S 
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Discussion 
 
 It is generally agreed that proinflammatory mediators, including cyto-
kines, are to a great extent responsible for metabolic changes associated with 
injury and surgery. Inflammatory response is associated with the release of a 
number of proinflammatory cytokines and acute-phase protein. TNFα, IL-1β 
and IL-6 are major mediators of the acute-phase response in humans [17]. IL-6 
is released to plasma in the early postoperative period. This has suggested that 
the magnitude of the damage of tissues may related to the ability of macro-
phages/monocytes and fibroblasts to release IL-6, but not TNFα and IL-1β. IL-6 
is produced by lymphoid and nonlymphoid cells and affects regulation of T and 
B cells, IG secretion, acute phase inflammatory reactions and haematopoiesis. 
TNF-α is an enhancer of IL-6 secretion and is produced primarily by activated 
monocytes and macrophages. Anaesthetic methods may affect the cytokine 
response to surgery changing nervous and hormone pathways.  
 Opioid drugs and local anaesthetics seem to have little effect on the 
inflammatory component of the stress response [15, 18]. Increasing the dose of 
opioids during general anaesthesia had little effect on the IL-6 response [18]. 
Combining regional with general anaesthesia suppressed the endocrine and 
metabolic response but had little influence on IL-6 increases [19]. Although it is 
not known by what mechanism ketamine suppresses the IL-6 [15]. Total intra-
venous anaesthesia (TIVA) with propofol and alfentanil are known to suppress 
IL-6 production in abdominal hystectomy [20]. Helmy et al. investigated 
cytokine production in response to TIVA in patients undergoing open and 
laparascopic cholecystectomy [21]. In their study TNFα and IL-6 increased 
after open cholecystectomy, but this response was absent in laparascopic 
cholecystectomy [21]. 
 Clements and Nimmo showed that the analgesic effect of ketamine 
occurred at a much lower plasma concentration (100 ng/ml) than the anaesthetic 
effects (700 ng/ml) [21]. In healthy volunteers, IV ketamine application in doses 
of 0.125 and 0.25 mg/kg increase the pain threshold. At this small dose, the 
incidence of side-effects does not seem to be clinically important [15]. Keta-
mine anaesthesia (2mg/kg) alone produces a dose-related increase in cardiovas-
cular stimulation and psychomimetic disturbance after surgery. Decreasing the 
dose of ketamine can modify these side-effects [15].  
 Some studies report the recent discovery of the N-Methyl-D-Aspartate 
(NMDA) receptor which seems to play a role in pain transmission and accor-
ding to other studies, ketamine binds to these receptors with a nonselective anta-
gonism, reducing wound hyperalgesia. The analgesic efficacy of ketamine is 
linked to activation of NMDA receptors of the dorsal horn of the spinal cord 
[23]. NMDA receptors at the spinal level prolong and amplify the nocioceptive 
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response (wind-up phenomenon). Ketamine acts on nicotinic and muscarinic 
receptors; it blocks sodium channels in the peripheral and central nervous sys-
tem and interacts with opioid receptors µ, δ and κ. Ketamine also acts as a non-
competitive antagonist at the phencyclidine receptor site in the NMDA receptor 
complex canal. This system is involved in the development and maintenance of 
secondary hyperalgesia after tissue injury [24]. 
 Mathiesen LC et al. demonstrateda lack of preemptive analgesic effect 
of (R)-ketamine in laparascopic cholecystectomy [25]. Our study reports that 
the preemptive application of a low dose of ketamine has a significant improve-
ment of postoperative analgesia in the first 8 hours after laparascopic cholescys-
tectomy. This preemptive analgesic effect is already seen in other abdominal 
surgical procedures [17], anterior cruciate ligament repair [16, 28] and abdomi-
nal hysopterectomy [26, 27]. 
 A small dose of ketamine, given before skin incision, decreases post-
operative pain, reduces morphine consumption and delays the patient’s request 
for analgesia after laparoscopic gynecological surgery [26]. Christophe Meni-
faux et al. observed that a single small dose of ketamine administered intraope-
ratively delays the first request for analgesic, produces a significant 50% mor-
phine–sparing effect during the first 48 hours after knee surgery performed 
under arthroscopy, and facilitates knee mobilization at 24 hours [28]. Preemp-
tive low-dose ketamine is able to produce adequate postoperative analgesia and 
increase the analgesic effect of tramadol [22]. Ketamine is the only NMDA 
antagonist approved by the Food and Drug Administration [29]. 
Some investigators have suggested that i.v. application of ketamine 
might have some advantages over epidural ketamine when administered with 
morphine in blocking nocioceptive sensitization [30]. Moreover, this beneficial 
effect may only be obtained after systematic administration [30]. 
 
 
Conclusion 
 
 In patients undergoing elective laparascopic cholecystectomy the 
addition of a small dose of ketamine (0.25 mg/kg-1) after induction of anaesthe-
sia resulted in attenuation a of the secretion of proinflammatory cytokines 
(TNFα, IL-1β, IL-6) during the first postoperative day. Preemptive use of keta-
mine as a potent noncompetitive NMDA antagonist can improve postoperative 
analgesia in the early postoperative period in these patients. 
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 Во оваа студија ние го оценувавме ефектот на малите дози на кетаминот 
врз продукцијата на TNFα, IL-1β, IL-6 и постоперативната болка кај пациенти за 
лапараскопска холецистектомија. 
 Педесет пациенти за елективна лапараскопска холецистектомија беа 
поделени во две еднакви групи. Пациентите во кетаминската група, n = 25, по 
воведот во анестезија добија 0,25 mg/kg-1 кетамин. Во исто време пациентите од 
контролната група, n = 25, добија еднаков волумен на изотоничен натриум 
хлорид. Во постоперативниот период, болката се оценуваше според визуелно 
аналогната скала (ВАС) во период од 30 мин, 1, 2, 4, 8, 18, 24 и 48 часа. TNFα, IL-
1β и IL-6 беа евалуирани пред започнување на хируршката итервенција, по 4, 18 и 
24 часа по операцијата.  
 Разликите на средните вредности на TNFα и IL-1β помеѓу двете испи-
тувани групи во постоперативниот период не се значителни. Средните вредности 
на IL-6 кај испитаниците од групата А се статистички значително пониски од 
средните вредности на IL-6 кај испитаниците од групата B по четвртиот час (p = 
0,00990), по осумнаесеттиот час (p = 0,00133) како и по 24 часа од операцијата (p 
= 0,00860). Разликата во интензитетот на болката според VAS скалата е статис-
тички значително помала кај групата А по 30 мин., 1, 2, 8 и 12 часа по опера-
тивната интервенција. 
 Додавање на мали дози на кетамин по воведот во анестезија кај пациенти 
кај кои се изведува лапараскопска холецистектомија резултира со промени во 
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секрецијата на TNFα, IL-1β, IL-6, но и доведува до редуцирање на постопе-
ративната болка. 
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